Pancreatic Cancer Research

ResearcherTokai UniversityNo recent work listed

Masayuki Tatemichi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5051-8591; OpenAlex author ID A5045530482. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
3
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. Evaluation of Erastin as a Therapeutic Agent Under Hypoxic Conditions in Pancreatic Cancer Cells. Last author DOI 10.21873/anticanres.15424↗
  2. An Adaptation System to Avoid Apoptosis via Autophagy Under Hypoxic Conditions in Pancreatic Cancer Cells. Last author DOI 10.21873/anticanres.11902↗
  3. Involvement of annexin A8 in the properties of pancreatic cancer. First author DOI 10.1002/mc.21961↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Satoshi Owada · 2 shared papers, 2017–2021 · strength 0.24
  2. Toshio Nakadate · 1 shared paper, 2014 · strength 0.07
  3. Harumi Hata · 1 shared paper, 2014 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.